<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">ALLERGIES</a></li><li><a href="#id2">REASON FOR REFERRAL</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">MEDICATIONS</a></li><li><a href="#id5">SOCIAL HISTORY</a></li><li><a href="#id6">PROBLEMS</a></li><li><a href="#id7">VITAL SIGNS</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">ASSESSMENTS</a></li><li><a href="#id10">PLAN OF TREATMENT</a></li><li><a href="#id11">Progress Notes</a></li><li><a href="#id12">History and Physical Notes</a></li><li><a href="#id13">Consultation Request Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">ALLERGIES</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR REFERRAL</a></h3><div><table width="100%" border="1"><tbody><tr><th>Diagnosis 1</th><td>Pain in right leg (M79.604)</td></tr><tr><th>Diagnosis 2</th><td>Pain in left leg (M79.605)</td></tr><tr><th>Diagnosis 3</th><td>Type 2 diabetes mellitus with peripheral vascular disease (E11.51)</td></tr><tr><th>Referral Organization</th><td>[REDACTED] MD PA</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>CHAMAH</td></tr><tr><th>Referring Provider Speciality</th><td>General Practice</td></tr><tr><th>Referred Provider Specialty</th><td>Vascular Surgery</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>FOLLOW UP RESULTS., MEDICATION REFILL.</div><h3><a name="id4" href="#toc">MEDICATIONS</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Folic Acid 1 MG</td><td ID="instruction1">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Farxiga 10 MG</td><td ID="instruction2">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Rosuvastatin Calcium 10 MG</td><td ID="instruction3">1 tablet Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Venlafaxine HCl ER 150 MG</td><td ID="instruction4">1 capsule with food Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Milk Thistle 1000 MG</td><td ID="instruction5">as directed Orally twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">metFORMIN HCl 500 MG</td><td ID="instruction6">1 tablet with a meal Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Memantine HCl 5 MG</td><td ID="instruction7">1 tablet Orally twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Fosamax 70 MG</td><td ID="instruction8">1 tablet 30 minutes before the first food, beverage or medicine of the day with plain water Orally once a week for 84</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Aspir-Low 81 MG</td><td ID="instruction9">1 tablet Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication10">OneTouch Ultra -</td><td ID="instruction10">USAR DIARIA for 50</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Metoprolol Succinate 100 MG</td><td ID="instruction11">1 capsule Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Simethicone 125 MG</td><td ID="instruction12">1 capsule after meals and at bedtime as needed Orally TID</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">OneTouch Delica Lancets 33G -</td><td ID="instruction13">USAR DIARIA for 90</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">SOCIAL HISTORY</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Unknown</td></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">PROBLEMS</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>SNOMED Code</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td ID="Problem1">PVD (peripheral vascular disease) (I73.9)</td><td/><td>Active</td><td>confirmed</td><td/><td>400047006</td><td/></tr><tr><td>Problem</td><td ID="Problem2">Type 2 diabetes mellitus with peripheral vascular disease (E11.51)</td><td/><td>Active</td><td>confirmed</td><td/><td>Type 2 diabetes mellitus with peripheral angiopathy (314902007)</td><td ID="problems2notes">DM type 2 with PVD, taking Metformin and Farxiga. As per PE peripheral pulses decreased</td></tr></tbody></table></div><h3><a name="id7" href="#toc">VITAL SIGNS</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>98.5 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Heart Rate</th><td>72 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure systolic</th><td>110 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Blood pressure diastolic</th><td>60 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Weight</th><td>101 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital6">BMI</th><td>19.08 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Height</th><td>61 in</td><td>[REDACTED]</td></tr><tr><th ID="vital8">Respiratory Rate</th><td>18 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital9">Oximetry</th><td>98 %</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>[REDACTED] MD PA</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Pain in right leg M79.604 ; Pain in left leg M79.605 ; Type 2 diabetes mellitus with peripheral vascular disease E11.51 ; Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; Hyperlipidemia, unspecified hyperlipidemia type E78.5 ; Type 2 diabetes mellitus with other circulatory complications E11.59 ; Essential (primary) hypertension I10 ; Senile degeneration of brain, not elsewhere classified G31.1 ; Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety F02.80 ; Major depressive disorder, recurrent, moderate F33.1 and Body mass index [BMI] 19.9 or less, adult Z68.1</td></tr></tbody></table></div><h3><a name="id9" href="#toc">ASSESSMENTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Pain in right leg (ICD-10 - M79.604)</td><td/><td>Vascular specialist evaluation requested, patient started Trental.</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Pain in left leg (ICD-10 - M79.605)</td><td/><td>Vascular specialist evaluation requested, patient started Trental.</td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Type 2 diabetes mellitus with peripheral vascular disease (ICD-10 - E11.51)</td><td>DM type 2 with PVD, taking Metformin and Farxiga. As per PE peripheral pulses decreased</td><td>DM type 2 with PVD, taking Metformin and Farxiga. As per PE peripheral pulses decreased.  Follow low carbs diet and increase physical activity.  Recommend to continue a walking program.  I will consider invasive interventions only for critical limb ischemia</td><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td>DM type 2 with Hyperlipidemia, Taking Metformin, Farxiga and Rosuvastatin. As per labs done [REDACTED] HbA1C 6.5 well controlled.</td><td>DM type 2 with Hyperlipidemia, Taking Metformin, Farxiga and Rosuvastatin. As per labs done [REDACTED] HbA1C 6.5 well controlled. Follow low carbs diet and increase physical activity.</td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Hyperlipidemia, unspecified hyperlipidemia type (ICD-10 - E78.5)</td><td>On Rosuvastatin</td><td>On Rosuvastatin.  Healthy lifestyle discussed with patient, including to limit saturated fats and avoid trans fats.</td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Type 2 diabetes mellitus with other circulatory complications (ICD-10 - E11.59)</td><td>DM type 2 with HTN, taking Metoprolol, Metformin, Farxiga.</td><td>DM type 2 with HTN, taking Metoprolol, Metformin, Farxiga.  Follow low carbs diet and increase physical activity. Type 2 Diabetes: Care Instructions material was printed</td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td>Taking Metoprolol</td><td>Taking Metoprolol.  Patient's blood pressure is controlled on current medication treatment. We will continue to monitor the patient closely. Recommended to follow a diet low in sodium. Followed by Cardiologist</td><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Senile degeneration of brain, not elsewhere classified (ICD-10 - G31.1)</td><td>As per Hospital records on [REDACTED] page 10 and on MRI done [REDACTED]</td><td>As per Hospital records on [REDACTED] page 10 and on MRI done [REDACTED]. Continue monitoring. </td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety (ICD-10 - F02.80)</td><td>Patient taking Memantine.,</td><td>Patient with Memory Loss on treatment with Memantine. </td><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Major depressive disorder, recurrent, moderate (ICD-10 - F33.1)</td><td>Taking Venlafaxine, Mirtazapine and Trazodone</td><td>Taking Venlafaxine</td><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Body mass index [BMI] 19.9 or less, adult (ICD-10 - Z68.1)</td><td/><td>BMI 19.08</td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Other</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">PLAN OF TREATMENT</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Pain in right leg</td><td>Vascular specialist evaluation requested, patient started Trental.</td></tr><tr><td ID="instructionpot2">Pain in left leg</td><td>Vascular specialist evaluation requested, patient started Trental.</td></tr><tr><td ID="instructionpot3">Type 2 diabetes mellitus with peripheral vascular disease</td><td>DM type 2 with PVD, taking Metformin and Farxiga. As per PE peripheral pulses decreased.  Follow low carbs diet and increase physical activity.  Recommend to continue a walking program.  I will consider invasive interventions only for critical limb ischemia</td></tr><tr><td ID="instructionpot4">Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</td><td>DM type 2 with Hyperlipidemia, Taking Metformin, Farxiga and Rosuvastatin. As per labs done [REDACTED] HbA1C 6.5 well controlled. Follow low carbs diet and increase physical activity.</td></tr><tr><td ID="instructionpot5">Hyperlipidemia, unspecified hyperlipidemia type</td><td>On Rosuvastatin.  Healthy lifestyle discussed with patient, including to limit saturated fats and avoid trans fats.</td></tr><tr><td ID="instructionpot6">Type 2 diabetes mellitus with other circulatory complications</td><td>DM type 2 with HTN, taking Metoprolol, Metformin, Farxiga.  Follow low carbs diet and increase physical activity. Type 2 Diabetes: Care Instructions material was printed</td></tr><tr><td ID="instructionpot7">Essential (primary) hypertension</td><td>Taking Metoprolol.  Patient's blood pressure is controlled on current medication treatment. We will continue to monitor the patient closely. Recommended to follow a diet low in sodium. Followed by Cardiologist</td></tr><tr><td ID="instructionpot8">Senile degeneration of brain, not elsewhere classified</td><td>As per Hospital records on [REDACTED] page 10 and on MRI done [REDACTED]. Continue monitoring. </td></tr><tr><td ID="instructionpot9">Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety</td><td>Patient with Memory Loss on treatment with Memantine. </td></tr><tr><td ID="instructionpot10">Major depressive disorder, recurrent, moderate</td><td>Taking Venlafaxine</td></tr><tr><td ID="instructionpot11">Body mass index [BMI] 19.9 or less, adult</td><td>BMI 19.08</td></tr></tbody></table><span class="content_span">Referrals</span><table width="100%" border="1"><thead><tr><th>Referral Date</th><th>Details</th></tr></thead><tbody><tr><td ID="referral1"/><td/></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Months, Reason: FOLLOW UP FOR BLOOD TEST.</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] F) <span class="bold">Acc No.</span> 11155 S <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>11155 S</td><td align="right"><span class="bold">Provider: </span>[REDACTED], MD, [REDACTED]</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>81 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   FOLLOW UP RESULTS.MEDICATION REFILL.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Constitutional</span>: <br/>       Patient is a female [REDACTED] hispanic who comes alone to the visit for results and medication refill.REF TO VASCULAR SURGERY FOR NEW EVALUATION. START TRAMTAL 400 MG BID60.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General/Constitutional</span>: <br/>      Denies Fatigue. Denies Fever. Denies Headache.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Denies Chest pain. Denies Cough.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Denies Claudication. Denies Cyanosis.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Denies Abdominal pain. Denies Constipation.   <br/>   <span class="Underline">Hematology</span>: <br/>      Denies Dizziness. Admits Easy bruising.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Denies Blood in urine. Denies Frequent urination.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Admits Arthritis. Admits Painful joints.   <br/>   <span class="Underline">Neurologic</span>: <br/>      Denies Balance difficulty. Denies Coordination. Denies Dizziness.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Denies Anxiety. Denies Depressed mood. Denies Difficulty sleeping.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Gyn History:</span> <br/>   Menarche:<br/>         Past the age of menarche: <span class="italics">Yes</span><br/>         Age of menarche: <span class="italics">14</span><br/>   Menopause:<br/>         Began at age: <span class="italics">55</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">OB History:</span> <br/>   Total pregnancies 2. <br/>   Total living children 2. <br/>   Abortion(s) 0. <br/>   Pregnancy # 2: normal spontaneous vaginal delivery (NSVD). </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> tubal ligation right knee replacement cataract-lens implants hernia hiatal Rt and Lt  Abdominal Hernia hammer toe stent kidney stone </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> No Hospitalization History.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased [REDACTED] yrs,  diagnosed with Other specified conditions influencing health status. Mother: deceased [REDACTED] yrs,  diagnosed with Other specified conditions influencing health status. 1 brother(s) , 2 sister(s)  - healthy. 1 son(s) , 1 daughter(s) . . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking Are you a: nonsmoker. <br/>   <span class="Underline">Drugs/Alcohol:</span> <br/>       Drugs <br/>         Have you used drugs other than those for medical reasons in the past 12 months? <span class="italics">No</span><br/>      Alcohol Screen (Audit-C) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">No</span><br/>         Points <span class="italics">0</span><br/>         Interpretation <span class="italics">Negative</span><br/>      Caffeine <br/>         Intake: <span class="italics">1-2 cups per day</span><br/>      Do you smoke marijuana?: Denies. <br/>      Do you drink alcohol?: No. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingMemantine HCl 5 MG Tablet 1 tablet Orally twice a day Folic Acid 1 MG Tablet 1 tablet Orally Once a day Farxiga 10 MG Tablet 1 tablet Orally Once a day Rosuvastatin Calcium 10 MG Tablet 1 tablet Orally Once a day Venlafaxine HCl ER 150 MG Capsule Extended Release 24 Hour 1 capsule with food Orally Once a day Milk Thistle 1000 MG Capsule as directed Orally twice a day Metoprolol Succinate 100 MG Capsule ER 24 Hour Sprinkle 1 capsule Orally Once a day Simethicone 125 MG Capsule 1 capsule after meals and at bedtime as needed Orally TID OneTouch Delica Lancets 33G - Miscellaneous USAR DIARIA   OneTouch Ultra - Strip USAR DIARIA   metFORMIN HCl 500 MG Tablet 1 tablet with a meal Orally Once a day Fosamax 70 MG Tablet 1 tablet 30 minutes before the first food, beverage or medicine of the day with plain water Orally once a week Taking Memantine HCl 5 MG Tablet 1 tablet Orally twice a day Taking Folic Acid 1 MG Tablet 1 tablet Orally Once a day Taking Farxiga 10 MG Tablet 1 tablet Orally Once a day Taking Rosuvastatin Calcium 10 MG Tablet 1 tablet Orally Once a day Taking Venlafaxine HCl ER 150 MG Capsule Extended Release 24 Hour 1 capsule with food Orally Once a day Taking Milk Thistle 1000 MG Capsule as directed Orally twice a day Taking Metoprolol Succinate 100 MG Capsule ER 24 Hour Sprinkle 1 capsule Orally Once a day Taking Simethicone 125 MG Capsule 1 capsule after meals and at bedtime as needed Orally TID Taking OneTouch Delica Lancets 33G - Miscellaneous USAR DIARIA   Taking OneTouch Ultra - Strip USAR DIARIA   Taking metFORMIN HCl 500 MG Tablet 1 tablet with a meal Orally Once a day Taking Fosamax 70 MG Tablet 1 tablet 30 minutes before the first food, beverage or medicine of the day with plain water Orally once a week Not-TakingAspir-Low 81 MG Tablet Delayed Release 1 tablet Orally Once a day Medication List reviewed and reconciled with the patientNot-Taking Aspir-Low 81 MG Tablet Delayed Release 1 tablet Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Temp: 98.5 F, HR: 72 /min, BP: 110/60 mm Hg, Wt: 101 lbs, BMI: 19.08 Index, Ht: 61 in, RR: 18 /min, Oxygen sat %: 98 %, Ht-cm: 154.94 cm, Wt-kg: 45.81 kg.</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:LIPID PANEL</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">TRIGLYCERIDES</td><td align="left">118<br/>(Ref Range: &lt;150 mg/dL)</td><td align="left">113<br/>(Ref Range: &lt;150 mg/dL)</td><td align="left">88<br/>(Ref Range: &lt;150 mg/dL)</td></tr><tr><td align="left">CHOLESTEROL, TOTAL</td><td class="bold" align="left">240    H<br/>(Ref Range: &lt;200 mg/dL)</td><td class="bold" align="left">207    H<br/>(Ref Range: &lt;200 mg/dL)</td><td align="left">172<br/>(Ref Range: &lt;200 mg/dL)</td></tr><tr><td align="left">HDL CHOLESTEROL</td><td align="left">77<br/>(Ref Range: &gt; OR = 50 mg/dL)</td><td align="left">72<br/>(Ref Range: &gt; OR = 50 mg/dL)</td><td align="left">84<br/>(Ref Range: &gt; OR = 50 mg/dL)</td></tr><tr><td align="left">LDL-CHOLESTEROL</td><td class="bold" align="left">139    H<br/>(Ref Range: mg/dL (calc))</td><td class="bold" align="left">113    H<br/>(Ref Range: mg/dL (calc))</td><td align="left">71<br/>(Ref Range: mg/dL (calc))</td></tr><tr><td align="left">CHOL/HDLC RATIO</td><td align="left">3.1<br/>(Ref Range: &lt;5.0 (calc))</td><td align="left">2.9<br/>(Ref Range: &lt;5.0 (calc))</td><td align="left">2.0<br/>(Ref Range: &lt;5.0 (calc))</td></tr><tr><td align="left">NON HDL CHOLESTEROL</td><td class="bold" align="left">163    H<br/>(Ref Range: &lt;130 mg/dL (calc))</td><td class="bold" align="left">135    H<br/>(Ref Range: &lt;130 mg/dL (calc))</td><td align="left">88<br/>(Ref Range: &lt;130 mg/dL (calc))</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:MICROALBUMIN, RANDOM URINE (W/CREATININE)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">CREATININE, RANDOM URINE</td><td align="left">98<br/>(Ref Range: 20-275 mg/dL)</td><td align="left">73<br/>(Ref Range: 20-275 mg/dL)</td><td align="left">59<br/>(Ref Range: 20-275 mg/dL)</td></tr><tr><td align="left">MICROALBUMIN</td><td align="left">0.9<br/>(Ref Range: See Note: mg/dL)</td><td align="left">0.7<br/>(Ref Range: See Note: mg/dL)</td><td align="left">0.4<br/>(Ref Range: See Note: mg/dL)</td></tr><tr><td align="left">MICROALBUMIN/CREATININE$RATIO, RANDOM URINE</td><td align="left">9<br/>(Ref Range: &lt;30 mg/g creat)</td><td align="left">10<br/>(Ref Range: &lt;30 mg/g creat)</td><td align="left">7<br/>(Ref Range: &lt;30 mcg/mg creat)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:BASIC METABOLIC PANEL</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">GLUCOSE</td><td class="bold" align="left">119    H<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">114    H<br/>(Ref Range: 65-99 mg/dL)</td><td class="bold" align="left">124    H<br/>(Ref Range: 65-99 mg/dL)</td></tr><tr><td align="left">UREA NITROGEN (BUN)</td><td align="left">23<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">16<br/>(Ref Range: 7-25 mg/dL)</td><td align="left">17<br/>(Ref Range: 7-25 mg/dL)</td></tr><tr><td align="left">CREATININE</td><td align="left">0.65<br/>(Ref Range: 0.60-0.95 mg/dL)</td><td align="left">0.60<br/>(Ref Range: 0.60-0.95 mg/dL)</td><td align="left">0.62<br/>(Ref Range: 0.60-0.95 mg/dL)</td></tr><tr><td align="left">BUN/CREATININE RATIO</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td><td align="left">SEE NOTE:<br/>(Ref Range: 6-22 (calc))</td></tr><tr><td align="left">SODIUM</td><td align="left">142<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">141<br/>(Ref Range: 135-146 mmol/L)</td><td align="left">139<br/>(Ref Range: 135-146 mmol/L)</td></tr><tr><td align="left">POTASSIUM</td><td class="bold" align="left">5.7    H<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.9<br/>(Ref Range: 3.5-5.3 mmol/L)</td><td align="left">4.3<br/>(Ref Range: 3.5-5.3 mmol/L)</td></tr><tr><td align="left">CHLORIDE</td><td align="left">99<br/>(Ref Range: 98-110 mmol/L)</td><td align="left">99<br/>(Ref Range: 98-110 mmol/L)</td><td class="bold" align="left">97    L<br/>(Ref Range: 98-110 mmol/L)</td></tr><tr><td align="left">CARBON DIOXIDE</td><td class="bold" align="left">34    H<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">31<br/>(Ref Range: 20-32 mmol/L)</td><td align="left">32<br/>(Ref Range: 20-32 mmol/L)</td></tr><tr><td align="left">CALCIUM</td><td align="left">10.4<br/>(Ref Range: 8.6-10.4 mg/dL)</td><td align="left">9.8<br/>(Ref Range: 8.6-10.4 mg/dL)</td><td align="left">10.0<br/>(Ref Range: 8.6-10.4 mg/dL)</td></tr><tr><td align="left">EGFR</td><td align="left">89<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">91<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td><td align="left">90<br/>(Ref Range: &gt; OR = 60 mL/min/1.73m2)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:HEPATIC FUNCTION PANEL</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">PROTEIN, TOTAL</td><td align="left">7.4<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">6.9<br/>(Ref Range: 6.1-8.1 g/dL)</td><td align="left">7.3<br/>(Ref Range: 6.1-8.1 g/dL)</td></tr><tr><td align="left">ALBUMIN</td><td align="left">4.5<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">4.2<br/>(Ref Range: 3.6-5.1 g/dL)</td><td align="left">4.6<br/>(Ref Range: 3.6-5.1 g/dL)</td></tr><tr><td align="left">GLOBULIN</td><td align="left">2.9<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.7<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td><td align="left">2.7<br/>(Ref Range: 1.9-3.7 g/dL (calc))</td></tr><tr><td align="left">ALBUMIN/GLOBULIN RATIO</td><td align="left">1.6<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.6<br/>(Ref Range: 1.0-2.5 (calc))</td><td align="left">1.7<br/>(Ref Range: 1.0-2.5 (calc))</td></tr><tr><td align="left">BILIRUBIN, TOTAL</td><td align="left">0.5<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.5<br/>(Ref Range: 0.2-1.2 mg/dL)</td><td align="left">0.5<br/>(Ref Range: 0.2-1.2 mg/dL)</td></tr><tr><td align="left">BILIRUBIN, DIRECT</td><td align="left">0.1<br/>(Ref Range: &lt; OR = 0.2 mg/dL)</td><td align="left">0.1<br/>(Ref Range: &lt; OR = 0.2 mg/dL)</td><td align="left">0.1<br/>(Ref Range: &lt; OR = 0.2 mg/dL)</td></tr><tr><td align="left">BILIRUBIN, INDIRECT</td><td align="left">0.4<br/>(Ref Range: 0.2-1.2 mg/dL (calc))</td><td align="left">0.4<br/>(Ref Range: 0.2-1.2 mg/dL (calc))</td><td align="left">0.4<br/>(Ref Range: 0.2-1.2 mg/dL (calc))</td></tr><tr><td align="left">ALKALINE PHOSPHATASE</td><td align="left">92<br/>(Ref Range: 37-153 U/L)</td><td align="left">111<br/>(Ref Range: 37-153 U/L)</td><td align="left">89<br/>(Ref Range: 37-153 U/L)</td></tr><tr><td align="left">AST</td><td align="left">21<br/>(Ref Range: 10-35 U/L)</td><td align="left">20<br/>(Ref Range: 10-35 U/L)</td><td align="left">21<br/>(Ref Range: 10-35 U/L)</td></tr><tr><td align="left">ALT</td><td align="left">16<br/>(Ref Range: 6-29 U/L)</td><td align="left">12<br/>(Ref Range: 6-29 U/L)</td><td align="left">15<br/>(Ref Range: 6-29 U/L)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC (INCLUDES DIFF/PLT)</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">WHITE BLOOD CELL COUNT</td><td align="left">6.1<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td><td align="left">6.2<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td><td align="left">7.4<br/>(Ref Range: 3.8-10.8 Thousand/uL)</td></tr><tr><td align="left">RED BLOOD CELL COUNT</td><td class="bold" align="left">5.52    H<br/>(Ref Range: 3.80-5.10 Million/uL)</td><td class="bold" align="left">5.37    H<br/>(Ref Range: 3.80-5.10 Million/uL)</td><td align="left">4.94<br/>(Ref Range: 3.80-5.10 Million/uL)</td></tr><tr><td align="left">HEMOGLOBIN</td><td class="bold" align="left">16.4    H<br/>(Ref Range: 11.7-15.5 g/dL)</td><td class="bold" align="left">15.8    H<br/>(Ref Range: 11.7-15.5 g/dL)</td><td align="left">14.6<br/>(Ref Range: 11.7-15.5 g/dL)</td></tr><tr><td align="left">HEMATOCRIT</td><td class="bold" align="left">52.9    H<br/>(Ref Range: 35.0-45.0 %)</td><td class="bold" align="left">50.5    H<br/>(Ref Range: 35.0-45.0 %)</td><td class="bold" align="left">45.9    H<br/>(Ref Range: 35.0-45.0 %)</td></tr><tr><td align="left">MCV</td><td align="left">95.8<br/>(Ref Range: 80.0-100.0 fL)</td><td align="left">94.0<br/>(Ref Range: 80.0-100.0 fL)</td><td align="left">92.9<br/>(Ref Range: 80.0-100.0 fL)</td></tr><tr><td align="left">MCH</td><td align="left">29.7<br/>(Ref Range: 27.0-33.0 pg)</td><td align="left">29.4<br/>(Ref Range: 27.0-33.0 pg)</td><td align="left">29.6<br/>(Ref Range: 27.0-33.0 pg)</td></tr><tr><td align="left">MCHC</td><td class="bold" align="left">31.0    L<br/>(Ref Range: 32.0-36.0 g/dL)</td><td class="bold" align="left">31.3    L<br/>(Ref Range: 32.0-36.0 g/dL)</td><td class="bold" align="left">31.8    L<br/>(Ref Range: 32.0-36.0 g/dL)</td></tr><tr><td align="left">RDW</td><td align="left">14.7<br/>(Ref Range: 11.0-15.0 %)</td><td class="bold" align="left">15.6    H<br/>(Ref Range: 11.0-15.0 %)</td><td align="left">12.7<br/>(Ref Range: 11.0-15.0 %)</td></tr><tr><td align="left">PLATELET COUNT</td><td align="left">310<br/>(Ref Range: 140-400 Thousand/uL)</td><td align="left">304<br/>(Ref Range: 140-400 Thousand/uL)</td><td align="left">287<br/>(Ref Range: 140-400 Thousand/uL)</td></tr><tr><td align="left">NEUTROPHILS</td><td align="left">66.7<br/>(Ref Range: %)</td><td align="left">70.5<br/>(Ref Range: %)</td><td align="left">78.4<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE NEUTROPHILS</td><td align="left">4069<br/>(Ref Range: 1500-7800 cells/uL)</td><td align="left">4371<br/>(Ref Range: 1500-7800 cells/uL)</td><td align="left">5802<br/>(Ref Range: 1500-7800 cells/uL)</td></tr><tr><td align="left">LYMPHOCYTES</td><td align="left">22.7<br/>(Ref Range: %)</td><td align="left">18.9<br/>(Ref Range: %)</td><td align="left">14.9<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE LYMPHOCYTES</td><td align="left">1385<br/>(Ref Range: 850-3900 cells/uL)</td><td align="left">1172<br/>(Ref Range: 850-3900 cells/uL)</td><td align="left">1103<br/>(Ref Range: 850-3900 cells/uL)</td></tr><tr><td align="left">MONOCYTES</td><td align="left">7.7<br/>(Ref Range: %)</td><td align="left">6.9<br/>(Ref Range: %)</td><td align="left">6.3<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE MONOCYTES</td><td align="left">470<br/>(Ref Range: 200-950 cells/uL)</td><td align="left">428<br/>(Ref Range: 200-950 cells/uL)</td><td align="left">466<br/>(Ref Range: 200-950 cells/uL)</td></tr><tr><td align="left">EOSINOPHILS</td><td align="left">2.6<br/>(Ref Range: %)</td><td align="left">3.4<br/>(Ref Range: %)</td><td align="left">0.0<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE EOSINOPHILS</td><td align="left">159<br/>(Ref Range: 15-500 cells/uL)</td><td align="left">211<br/>(Ref Range: 15-500 cells/uL)</td><td class="bold" align="left">0    L<br/>(Ref Range: 15-500 cells/uL)</td></tr><tr><td align="left">BASOPHILS</td><td align="left">0.3<br/>(Ref Range: %)</td><td align="left">0.3<br/>(Ref Range: %)</td><td align="left">0.4<br/>(Ref Range: %)</td></tr><tr><td align="left">ABSOLUTE BASOPHILS</td><td align="left">18<br/>(Ref Range: 0-200 cells/uL)</td><td align="left">19<br/>(Ref Range: 0-200 cells/uL)</td><td align="left">30<br/>(Ref Range: 0-200 cells/uL)</td></tr><tr><td align="left">MPV</td><td align="left">10.2<br/>(Ref Range: 7.5-12.5 fL)</td><td align="left">11.0<br/>(Ref Range: 7.5-12.5 fL)</td><td align="left">10.3<br/>(Ref Range: 7.5-12.5 fL)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:URINALYSIS, COMPLETE</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">COLOR</td><td align="left">YELLOW<br/>(Ref Range: YELLOW)</td><td align="left">YELLOW<br/>(Ref Range: YELLOW)</td><td align="left">YELLOW<br/>(Ref Range: YELLOW)</td></tr><tr><td align="left">APPEARANCE</td><td align="left">CLEAR<br/>(Ref Range: CLEAR)</td><td align="left">CLEAR<br/>(Ref Range: CLEAR)</td><td align="left">CLEAR<br/>(Ref Range: CLEAR)</td></tr><tr><td align="left">BILIRUBIN</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">KETONES</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">SPECIFIC GRAVITY</td><td align="left">1.032<br/>(Ref Range: 1.001-1.035)</td><td align="left">1.026<br/>(Ref Range: 1.001-1.035)</td><td align="left">1.022<br/>(Ref Range: 1.001-1.035)</td></tr><tr><td align="left">OCCULT BLOOD</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">PH</td><td align="left">6.5<br/>(Ref Range: 5.0-8.0)</td><td align="left">6.0<br/>(Ref Range: 5.0-8.0)</td><td align="left">5.5<br/>(Ref Range: 5.0-8.0)</td></tr><tr><td align="left">PROTEIN</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">NITRITE</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">LEUKOCYTE ESTERASE</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td><td align="left">NEGATIVE<br/>(Ref Range: NEGATIVE)</td></tr><tr><td align="left">WBC</td><td align="left">0-5<br/>(Ref Range: &lt; OR = 5 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td></tr><tr><td align="left">RBC</td><td align="left">0-2<br/>(Ref Range: &lt; OR = 2 /HPF)</td><td align="left">0-2<br/>(Ref Range: &lt; OR = 2 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 2 /HPF)</td></tr><tr><td align="left">SQUAMOUS EPITHELIAL CELLS</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: &lt; OR = 5 /HPF)</td></tr><tr><td align="left">BACTERIA</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /HPF)</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /HPF)</td></tr><tr><td align="left">HYALINE CAST</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /LPF)</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /LPF)</td><td align="left">NONE SEEN<br/>(Ref Range: NONE SEEN /LPF)</td></tr><tr><td align="left">GLUCOSE</td><td class="bold" align="left">3+    A<br/>(Ref Range: NEGATIVE)</td><td class="bold" align="left">3+    A<br/>(Ref Range: NEGATIVE)</td><td class="bold" align="left">3+    A<br/>(Ref Range: NEGATIVE)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:HEMOGLOBIN A1c</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">HEMOGLOBIN A1c</td><td class="bold" align="left">6.5    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td><td class="bold" align="left">6.8    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td><td class="bold" align="left">6.9    H<br/>(Ref Range: &lt;5.7 % of total Hgb)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:VITAMIN B12</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">VITAMIN B12</td><td align="left">729<br/>(Ref Range: 200-1100 pg/mL)</td><td align="left">467<br/>(Ref Range: 200-1100 pg/mL)</td><td align="left">479<br/>(Ref Range: 200-1100 pg/mL)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:TSH</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">TSH</td><td align="left">1.57<br/>(Ref Range: 0.40-4.50 mIU/L)</td><td align="left">1.69<br/>(Ref Range: 0.40-4.50 mIU/L)</td><td align="left">1.51<br/>(Ref Range: 0.40-4.50 mIU/L)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:VITAMIN D,25-OH,TOTAL,IA</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">VITAMIN D,25-OH,TOTAL,IA</td><td align="left">38<br/>(Ref Range: 30-100 ng/mL)</td><td align="left">46<br/>(Ref Range: 30-100 ng/mL)</td><td align="left">40<br/>(Ref Range: 30-100 ng/mL)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      GENERAL APPEARANCE: in no acute distress, , calm and relaxed, cooperative, alert, female. <br/>      HEAD: normocephalic,  atraumatic. <br/>      EYES: pupils equal, round, reactive to light and accommodation. <br/>      EARS: normal. <br/>      NOSE: no lesions. <br/>      ORAL CAVITY: mucosa moist. <br/>      THROAT: clear. <br/>      NECK/THYROID: neck supple, full range of motion,  no cervical lymphadenopathy. <br/>      LYMPH NODES: normal. <br/>      SKIN: senile purpura noted on forearms.. <br/>      HEART: no murmurs,  regular rate and rhythm,  S1, S2 normal. <br/>      LUNGS: clear to auscultation bilaterally. <br/>      CHEST: normal. <br/>      BREASTS: not examined. <br/>      ABDOMEN: bowel sounds present, no guarding or rigidity. <br/>      RECTAL: not examined. <br/>      BACK: normal. <br/>      FEMALE GENITOURINARY: not examined. <br/>      EXTREMITIES: no clubbing, cyanosis, or edema. <br/>      PERIPHERAL PULSES: , decreased distal pulses. <br/>      NEUROLOGIC: nonfocal, alert and oriented, normal strength, tone and reflexes. <br/>      PSYCH: alert, oriented, cognitive function intact.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Pain in right leg - M79.604 (Primary) 2. Pain in left leg - M79.605 3. Type 2 diabetes mellitus with peripheral vascular disease - E11.51, DM type 2 with PVD, taking Metformin and Farxiga. As per PE peripheral pulses decreased 4. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin - E11.69, DM type 2 with Hyperlipidemia, Taking Metformin, Farxiga and Rosuvastatin. As per labs done [REDACTED] HbA1C 6.5 well controlled. 5. Hyperlipidemia, unspecified hyperlipidemia type - E78.5, On Rosuvastatin 6. Type 2 diabetes mellitus with other circulatory complications - E11.59, DM type 2 with HTN, taking Metoprolol, Metformin, Farxiga. 7. Essential (primary) hypertension - I10, Taking Metoprolol 8. Senile degeneration of brain, not elsewhere classified - G31.1, As per Hospital records on [REDACTED] page 10 and on MRI done [REDACTED] 9. Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety - F02.80, Patient taking Memantine., 10. Major depressive disorder, recurrent, moderate - F33.1, Taking Venlafaxine, Mirtazapine and Trazodone 11. Body mass index [BMI] 19.9 or less, adult - Z68.1 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Pain in right leg</span> <br/>Notes: Vascular specialist evaluation requested, patient started Trental.          <br/> Referral To:Vascular Surgery<br/>              Reason:<br/></td></tr><tr><td/></tr><tr><td><span class="bold">2. Pain in left leg</span> <br/>Notes: Vascular specialist evaluation requested, patient started Trental.          <br/> Referral To:Vascular Surgery<br/>              Reason:<br/></td></tr><tr><td/></tr><tr><td><span class="bold">3. Type 2 diabetes mellitus with peripheral vascular disease</span> <br/>Notes: DM type 2 with PVD, taking Metformin and Farxiga. As per PE peripheral pulses decreased.  Follow low carbs diet and increase physical activity.  Recommend to continue a walking program.  I will consider invasive interventions only for critical limb ischemia          <br/> Referral To:Vascular Surgery<br/>              Reason:<br/></td></tr><tr><td/></tr><tr><td><span class="bold">4. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</span> <br/>Notes: DM type 2 with Hyperlipidemia, Taking Metformin, Farxiga and Rosuvastatin. As per labs done [REDACTED] HbA1C 6.5 well controlled. Follow low carbs diet and increase physical activity.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Hyperlipidemia, unspecified hyperlipidemia type</span> <br/>Notes: On Rosuvastatin.  Healthy lifestyle discussed with patient, including to limit saturated fats and avoid trans fats.  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Type 2 diabetes mellitus with other circulatory complications</span> <br/>Notes: DM type 2 with HTN, taking Metoprolol, Metformin, Farxiga.  Follow low carbs diet and increase physical activity. Type 2 Diabetes: Care Instructions material was printed  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Essential (primary) hypertension</span> <br/>Notes: Taking Metoprolol.  Patient's blood pressure is controlled on current medication treatment. We will continue to monitor the patient closely. Recommended to follow a diet low in sodium. Followed by Cardiologist  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Senile degeneration of brain, not elsewhere classified</span> <br/>Notes: As per Hospital records on [REDACTED] page 10 and on MRI done [REDACTED]. Continue monitoring.   </td></tr><tr><td/></tr><tr><td><span class="bold">9. Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety</span> <br/>Notes: Patient with Memory Loss on treatment with Memantine.   </td></tr><tr><td/></tr><tr><td><span class="bold">10. Major depressive disorder, recurrent, moderate</span> <br/>Notes: Taking Venlafaxine  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Body mass index [BMI] 19.9 or less, adult</span> <br/>Notes: BMI 19.08  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 3008F BMI3074F SYST BP LT 130 MM HG3078F DIAST BP &lt; 80 MM HG</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  YOUR PREVENTIVE WELLNESS PLAN: <br/>       BMI, Height, and Weight: <br/>          My BMI, height, and weight were taken on: <span class="italics">[REDACTED]</span><br/>       Blood Pressure: <br/>          My blood pressure was last taken on: <span class="italics">[REDACTED]</span><br/>       Cholesterol Testing: <br/>          My Cholesterol was last tested on: <span class="italics">[REDACTED]</span><br/>       Diabetes Screening: <br/>          Screening for diabetes was last done on: <span class="italics">[REDACTED]</span><br/>       Major Risk Factors: <br/>          Your Risk Factors Include: <span class="italics">Diabetes, Fall Risk, Hypertension</span><br/>       Recommendations For Improvement  <br/>          The recommendations are: <span class="italics">Diet, Exercise, Weight management</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Months (Reason: FOLLOW UP FOR BLOOD TEST.)</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td colspan="2"><content><span class="bold">Images:</span></content></td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , MD  on [REDACTED] 12:16 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], MD, [REDACTED]</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id12" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="24">General Examination</td><td>GENERAL APPEARANCE:</td><td colspan="2">in no acute distress, , calm and relaxed, cooperative, alert, female</td></tr><tr><td>HEAD:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>EYES:</td><td colspan="2">pupils equal, round, reactive to light and accommodation</td></tr><tr><td>EARS:</td><td colspan="2">normal</td></tr><tr><td>NOSE:</td><td colspan="2">no lesions</td></tr><tr><td>THROAT:</td><td colspan="2">clear</td></tr><tr><td>NECK/THYROID:</td><td colspan="2">neck supple, full range of motion, no cervical lymphadenopathy</td></tr><tr><td>HEART:</td><td colspan="2">no murmurs, regular rate and rhythm, S1, S2 normal</td></tr><tr><td>CHEST:</td><td colspan="2">normal</td></tr><tr><td>LUNGS:</td><td colspan="2">clear to auscultation bilaterally</td></tr><tr><td>ABDOMEN:</td><td colspan="2">bowel sounds present, no guarding or rigidity</td></tr><tr><td>NEUROLOGIC:</td><td colspan="2">nonfocal, alert and oriented, normal strength, tone and reflexes</td></tr><tr><td>SKIN:</td><td colspan="2">senile purpura noted on forearms.</td></tr><tr><td>EXTREMITIES:</td><td colspan="2">no clubbing, cyanosis, or edema</td></tr><tr><td>PERIPHERAL PULSES:</td><td colspan="2">, decreased distal pulses</td></tr><tr><td>BACK:</td><td colspan="2">normal</td></tr><tr><td>BREASTS:</td><td colspan="2">not examined</td></tr><tr><td>MUSCULOSKELETAL:</td><td colspan="2"/></tr><tr><td>LYMPH NODES:</td><td colspan="2">normal</td></tr><tr><td>RECTAL:</td><td colspan="2">not examined</td></tr><tr><td>PSYCH:</td><td colspan="2">alert, oriented, cognitive function intact</td></tr><tr><td>FEMALE GENITOURINARY:</td><td colspan="2">not examined</td></tr><tr><td>ORAL CAVITY:</td><td colspan="2">mucosa moist</td></tr><tr><td>PODIATRIC:</td><td colspan="2"/></tr></tbody></table><br/></li></ul></div><h3><a name="id13" href="#toc">Consultation Request Notes</a></h3><div><table width="100%" border="1"><tbody><tr><th>Referral Date</th><th>Referring Provider</th><th>Referred Provider</th><th>Notes</th></tr><tr ID="ConsultationNote1"><td>[REDACTED]</td><td>[REDACTED]</td><td>, </td><td/></tr></tbody></table></div><br/><br/>
</body></html>